![Monitoring Hormone Therapy with 24-Hour Urine Testing: A Menopause Case Study]()
by NDNR | Feb 26, 2011 | 2011 | February, Anti-Aging, Endocrinology, Fertility, Women's Health
Pushpa Larsen, ND As more NDs venture into the use of bioidentical hormones for treating symptoms of menopause and preventing age-related degeneration, it is incumbent on us to know that we are using these therapies in safe and effective ways. Presented herein is a...
![Monitoring Hormone Therapy with 24-Hour Urine Testing: A Menopause Case Study]()
by Razi Ann Berry | Feb 17, 2011 | 2011 | February, Products and Services
Contact: Michael Berger, Media Relations February 16, 2011 412.471.0840, berger@krome.com DOUGLAS LABORATORIES® PITTSBURGH, PA – Douglas Laboratories announces that Bioenergy Life Science, Inc. of Minneapolis, Minnesota, has granted it exclusive North America...
by NDNR | Feb 16, 2011 | 2011 | February, Education
David Schleich, PhD One would expect that our students would bring with them into their first year more than adequate writing, reading, speaking and listening skills to get through medical school. Such skills are, after all, fundamental for professional success....
by NDNR | Feb 15, 2011 | 2011 | February, Anxiety/Depression/Mental Health, Mind/Body, Neurology, Oncology, Women's Health
Jacob Schor, ND Current evidence suggests that selective serotonin reuptake inhibitors (SSRIs) may reduce the effectiveness of tamoxifen citrate in preventing breast cancer recurrence. This has special relevance because SSRIs are now widely prescribed to treat hot...
by NDNR | Feb 15, 2011 | 2011 | February, Environmental Medicine, Oncology, Women's Health
Marianne Marchese, ND Over the years, there has been a steady rise in women’s health conditions such as breast cancer and endometriosis. Some say the increase is owing to better screening and testing. This may be partially true; however, during this past half century,...
